myBiometry

myBiometry Raises $5 Million in Oversubscribed Seed Round to Advance Next-Generation Asthma and COPD Care

Antonette Ho2024-11-29T17:00:46-05:00Biometry Inc. (myBiometry), an asthma and COPD diagnostic and remote monitoring company, announced that it has successfully raised $5 million in an oversubscribed Seed funding round. The round was led by Dexcom Ventures, with participation from CareSource Indiana, Elevate Ventures, and other investor groups. This funding will advance the development of the company’s fenoTRACK solution, a breakthrough device designed to empower asthma and COPD patients by providing data to enable early detection of exacerbations. “We’re excited to partner with Dexcom...

INVEST Pitch Perfect winner: myBiometry aims to prevent asthma attacks long before they happen

Ziad2022-11-25T13:59:57-05:00Nationwide, more than 25 million people have asthma, including about 20 million adults and 5.1 million children and adolescents. If not well-controlled, the chronic condition can cause airways to swell and narrow, making it hard to breathe. This is called an asthma attack, and in a single year, more than 10 million people have one, according to the Centers for Disease Control and Prevention, resulting in 1.6 million emergency room visits and over 3,500 deaths. Now a Boston-based startup, myBiometry, is...

Here are the winners of the INVEST Pitch Perfect contest

Ziad2022-11-25T13:59:57-05:00The MedCity INVEST Pitch Perfect contest saw some compelling presentations by four groups of entrepreneurs seeking to make a difference in healthcare. They addressed myriad pain points in care coordination, care delivery, the patient experience and improving the collection and analysis of data for clinical decision support. Startups competed across four tracks. Teams of three judges evaluated startups on criteria that included completeness of overall plan, business idea, market opportunity, business model and the founder(s)’ experience. Here’s a look at...